Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
B8Fk | Xetra | EUR | Delayed | |
B8Fk | TradeGate | EUR | Delayed | |
B8Fk | Frankfurt | EUR | Delayed |
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. It also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
Name | Age | Since | Title |
---|---|---|---|
Humphrey Rang | - | - | Head of the Scientific Advisory Board |
Karlheinz Schmelig | 58 | 2021 | Member of the Supervisory Board |
Heikki Lanckriet | 47 | 2021 | Member of the Supervisory Board |
Helge Lubenow | 55 | 2021 | Member of the Supervisory Board |
Jorgen Tielmann | 54 | 2021 | Vice-Chairman of the Supervisory Board |
Wilhelm Konrad-Thomas Zours | 63 | 2021 | Chairman of the Supervisory Board |
Karin Lergenmuller | 65 | 2022 | Member of Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review